Kinetics of (+)-tubocurarine blockade at the neuromuscular junction
- PMID: 1884116
- PMCID: PMC1908381
- DOI: 10.1111/j.1476-5381.1991.tb09835.x
Kinetics of (+)-tubocurarine blockade at the neuromuscular junction
Abstract
1. Although (+)-tubocurarine (Tc) is classically considered to be a competitive antagonist at the neuromuscular junction, kinetic details of the interaction remain unclear. 2. We studied the competitive action of Tc on the nicotinic receptor at the frog neuromuscular junction using a quantitative analysis of the generation phase of miniature endplate currents (m.e.p.cs) recorded in Ringer solution (20 degrees C) under voltage clamp (-90 mV) in the absence or presence of 1-5 microM Tc. Under control conditions four neurotransmission parameters were estimated by non-linear regression using a mathematical model of synaptic transmission incorporating transmitter release, diffusion, hydrolysis, receptor binding and channel gating. These parameters were then used in a further regression to estimate binding rate constants for Tc at the same endplate. Allowance was made for open channel block by Tc, which under the conditions of this study was only a small component of total blockade. 3. The results suggest that Tc binds to the two agonist recognition sites on the nicotinic receptor with equal affinity (stoichiometric KDs of 2.2 and 8.8 microM), and that most of the functional blockade at concentrations up to 5 microM is due to occupancy of only one site. 4. The association rate constant for Tc binding to sites on the nicotinic acetylcholine receptor appears to be very fast (k+D = 8.9 x 10(8) M-1 s-1) and comparable to that for acetylcholine (ACh). 5. In the brief time during which an m.e.p.c. is generated (approximately 200 microseconds, reversal of Tc blockade by transiently high concentrations of ACh seems to be kinetically limited.
Similar articles
-
The interaction between hexamethonium and tubocurarine on the rat neuromuscular junction.Br J Pharmacol. 1984 Mar;81(3):519-31. doi: 10.1111/j.1476-5381.1984.tb10105.x. Br J Pharmacol. 1984. PMID: 6141831 Free PMC article.
-
Interactions of d-tubocurarine with the nicotinic acetylcholine receptor/channel molecule.J Pharmacol Exp Ther. 1982 Jan;220(1):172-7. J Pharmacol Exp Ther. 1982. PMID: 6273528
-
Run-down of neuromuscular transmission during repetitive nerve activity by nicotinic antagonists is not due to desensitization of the postsynaptic receptor.Br J Pharmacol. 1991 Apr;102(4):817-22. doi: 10.1111/j.1476-5381.1991.tb12258.x. Br J Pharmacol. 1991. PMID: 1677297 Free PMC article.
-
Compartmentalization of acetylcholine receptor gene expression during development of the neuromuscular junction.Cold Spring Harb Symp Quant Biol. 1990;55:381-96. doi: 10.1101/sqb.1990.055.01.039. Cold Spring Harb Symp Quant Biol. 1990. PMID: 2132828 Review. No abstract available.
-
Conformation, action, and mechanism of action of neuromuscular blocking muscle relaxants.Pharmacol Ther. 2003 May;98(2):143-69. doi: 10.1016/s0163-7258(03)00030-5. Pharmacol Ther. 2003. PMID: 12725867 Review.
Cited by
-
Physiologic-pharmacologic interpretation of the constants in the Hill equation for neuromuscular block: a hypothesis.J Pharmacokinet Pharmacodyn. 2002 Apr;29(2):189-206. doi: 10.1023/a:1019759725394. J Pharmacokinet Pharmacodyn. 2002. PMID: 12361243
-
An extended pharmacokinetic/pharmacodynamic model describing quantitatively the influence of plasma protein binding, tissue binding, and receptor binding on the potency and time course of action of drugs.J Pharmacokinet Biopharm. 1996 Feb;24(1):45-77. doi: 10.1007/BF02353510. J Pharmacokinet Biopharm. 1996. PMID: 8827583
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources